These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 30613963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
    Adjei Boakye E, Wang M, Sharma A, Jenkins WD, Osazuwa-Peters N, Chen B, Lee M, Schootman M.
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
    [Abstract] [Full Text] [Related]

  • 4. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
    Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I.
    J Clin Oncol; 2011 Feb 20; 29(6):739-46. PubMed ID: 21189382
    [Abstract] [Full Text] [Related]

  • 5. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS, Sikora AG, Baxi SS, Morris LG.
    Cancer; 2013 May 15; 119(10):1832-7. PubMed ID: 23423883
    [Abstract] [Full Text] [Related]

  • 6. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL, Jain KS, Morris LG.
    Thyroid; 2015 Jun 15; 25(6):681-7. PubMed ID: 25851829
    [Abstract] [Full Text] [Related]

  • 7. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R, Mahale P, Sonawane K, Sikora AG, Chhatwal J, Schmeler KM, Sigel K, Cantor SB, Chiao EY, Deshmukh AA.
    JAMA Netw Open; 2018 Sep 07; 1(5):e181999. PubMed ID: 30646145
    [Abstract] [Full Text] [Related]

  • 8. Risk of second primary malignancies in survivors of pancreatic neuroendocrine neoplasms from 2000 to 2018.
    Yang Z, Liu L, Leng K, Shi G.
    J Gastroenterol Hepatol; 2023 Sep 07; 38(9):1474-1484. PubMed ID: 37114675
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E, Buchanan P, Hinyard L, Osazuwa-Peters N, Schootman M, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2018 Aug 01; 144(8):727-737. PubMed ID: 30027284
    [Abstract] [Full Text] [Related]

  • 13. Risk of second primary malignancy in patients with sinonasal tumors: a population-based cohort study.
    Ganti A, Plitt MA, Kuan EC, Kuhar HN, Batra PS, Tajudeen BA.
    Int Forum Allergy Rhinol; 2018 Jun 01; 8(6):756-762. PubMed ID: 29381260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
    Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR, Paulus A, Aulakh S, Iqbal M, Manochakian R, Tan W, Chanan-Khan A, Ailawadhi M.
    Blood Cancer J; 2019 Sep 30; 9(10):75. PubMed ID: 31570695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
    Khanal A, Budhathoki N, Singh VP, Shah BK.
    Anticancer Res; 2017 Apr 30; 37(4):2033-2036. PubMed ID: 28373478
    [Abstract] [Full Text] [Related]

  • 20. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
    Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I.
    Cancer; 2011 Oct 01; 117(19):4439-46. PubMed ID: 21432843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.